Jacob George
Impact in
- Hepatology top 0.05%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Epidemiology top 0.02%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Adipokines, Inflammation, and Metabolic Diseases
Papers in
- Epidemiology 143
- Liver Disease Diagnosis and Treatment 102
- Hepatitis B Virus Studies 32
- Adipokines, Inflammation, and Metabolic Diseases 18
- Hepatology 101
- Hepatitis C virus research 72
- Co-authors
- Elisabetta Bugianesi (11 shared papers)Mohammed Eslam (11 shared papers)M. Marietti (2 shared papers)Timothy Hardy (1 shared paper)Quentin M. Anstee (1 shared paper)Linda Henry (1 shared paper)Zobair M. Younossi (1 shared paper)Yehuda Shoenfeld (51 shared papers)
- Journals
- Journal of Hepatology (23 papers)Hepatology (23 papers)PLoS ONE (19 papers)Atherosclerosis (17 papers)Lupus (10 papers)
- Partner nations
- IsraelAustraliaUnited States
In The Last Decade
Jacob George
596 papers receiving 30.1k citations
Jacob George's Hit Papers
Peers
Comparison fields: 5 of 198
- Hepatology 6.9k
- Epidemiology 13.5k
- Endocrinology, Diabetes and Metabolism 3.5k
- Immunology 4.1k
- Rheumatology 2.3k
Countries citing papers authored by Jacob George
This map shows the geographic impact of Jacob George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob George more than expected).
Fields of papers citing papers by Jacob George
This network shows the impact of papers produced by Jacob George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob George. The network helps show where Jacob George may publish in the future.
Co-authors
The 25 scholars most cited alongside Jacob George, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 625 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention Hit paper breakdown → | 2017 | 3960 |
| 2 | IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy Hit paper breakdown → | 2009 | 1463 |
| 3 | Beyond insulin resistance in NASH: TNF-α or adiponectin? Hit paper breakdown → | 2004 | 790 |
| 4 | The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Hit paper breakdown → | 2018 | 737 |
| 5 | Aerobic Exercise Training Reduces Hepatic and Visceral Lipids in Obese Individuals Without Weight Loss† Hit paper breakdown → | 2009 | 491 |
| 6 | Visceral fat Hit paper breakdown → | 2008 | 475 |
| 7 | Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis Hit paper breakdown → | 2011 | 449 |
| 8 | 2006 | 435 | |
| 9 | Animal models of nonalcoholic fatty liver disease Hit paper breakdown → | 2010 | 416 |
| 10 | Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis Hit paper breakdown → | 2012 | 395 |
| 11 | Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2013 | 385 |
| 12 | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission Hit paper breakdown → | 2019 | 384 |
| 13 | 2011 | 371 | |
| 14 | Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression Hit paper breakdown → | 2017 | 349 |
| 15 | Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review Hit paper breakdown → | 2016 | 345 |
| 16 | 1996 | 300 | |
| 17 | 2001 | 295 | |
| 18 | 1999 | 278 | |
| 19 | 2007 | 276 | |
| 20 | 2006 | 261 |
About Jacob George
Jacob George is a scholar working on Epidemiology, Hepatology, Immunology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 625 papers that have together received 30.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (102 papers), Hepatitis C virus research (72 papers), Atherosclerosis and Cardiovascular Diseases (52 papers), Systemic Lupus Erythematosus Research (45 papers), Hepatitis B Virus Studies (32 papers), Angiogenesis and VEGF in Cancer (19 papers), Diet, Metabolism, and Disease (18 papers) and Adipokines, Inflammation, and Metabolic Diseases (18 papers). The work is most often cited by research in Hepatology (6.9k citations), Epidemiology (13.5k citations), Endocrinology, Diabetes and Metabolism (3.5k citations), Immunology (4.1k citations) and Rheumatology (2.3k citations). Jacob George has collaborated with scholars based in Israel, Australia and United States. Frequent co-authors include Elisabetta Bugianesi, Mohammed Eslam, M. Marietti, Timothy Hardy, Quentin M. Anstee, Linda Henry, Zobair M. Younossi, Yehuda Shoenfeld, Nathan A. Johnson and Gad Keren. Their work appears in journals such as Journal of Hepatology, Hepatology, PLoS ONE, Atherosclerosis and Lupus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.